The French Pharmaceutical Companies Association (Les Entreprises du Médicament -Leem) is a French industry association which represents drug companies operating in France. It provides its members with studies and analyses on major issues and current events in the industry.
The Leem has been supporting the work of TSE economists since 2019, through the TSE Health Center. and renewed this partnership in 2025. The research initiative focuses on the value of drug. Activities conducted within this multi-year partnership include the production of scientific publications and initiatives aimed at disseminating research results on a wide range of topics, from drug shortages, the funding of breakthrough innovation, to drug price regulation and public policies.
Upcoming conferences
Angélique Acquatella, Pierre Dubois, and Jean Tirole, 4th Health Economics Conference, Auditoriums A3-A4, June 16–17, 2026.
Past conferences
3rd Health Economics Conference, TSE, June 18–19, 2025, room Auditorium A3 et Auditorium A4.
2nd Health Economics Conference, TSE, June 19–20, 2024, room Auditorium A3 JJ Laffont and Auditorium A4.
1st CEPR Conference in Health Economics, TSE Building, June 19, 09:00 to June 20, 2023, 17:00.
Workshop: Innovation, regulation and organization in healthcare, Paris, June 27, 2022, 14:30.
Workshop on the Economics of Antibiotics, TSE, December 6, 2021, room Auditorium A3.
Contact
Scientific Director Pierre Dubois
Head of Research Partnerships and Centers Eve Séjalon
